Kevin Bitterman, Director at Akero Therapeutics, Inc. (AKRO), sold 13,000 shares at $28.93 ($376K) on 2020-10-09, disclosed to the SEC on 2020-10-14.
Open-market sale of $376k AKRO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| IRON | SELL | 2026-09-03 | $4.4M | — | Filing → |
| IRON | SELL | 2025-12-18 | $69K | — | Filing → |
| IRON | SELL | 2025-12-16 | $33.1M | — | Filing → |